Main Content
News

September 02, 2019
Unique fingerprint: What makes nerve cells unmistakable?
Protein variations that result from the process of alternative splicing control the identity and function of nerve cells in the brain. This allows…

August 02, 2019
How brain tumors promote their own growth
Research groups at the Biozentrum of the University of Basel, in collaboration with the Department of Biomedicine and the University Hospital Basel,…

July 25, 2019
One or the other: Why strength training might come at the expense of endurance muscles
The neurotransmitter brain-derived neurotrophic factor (BDNF) acts in the muscle, so that during strength training endurance muscle fiber number is…

July 25, 2019
How neuromuscular connections are maintained after nerve lesions
After nerve injury, the protein complex mTORC1 takes over an important function in skeletal muscle to maintain the neuromuscular junction, the synapse…

July 12, 2019
Speed controllers for protein production
The translation of the genetic code into proteins is a vital process in any cell. Prof. Mihaela Zavolan’s team at the Biozentrum, University of Basel,…

July 01, 2019
Very first “Summer Science Academy” for high school students
The first Basel Summer Science Academy is taking place at the University of Basel this year. In a two-week course, sixteen high school students from…

June 25, 2019
New contents: Neuronal Parkinson inclusions are different than expected
An international team of researchers, including Prof. Henning Stahlberg from the Biozentrum, University of Basel, challenges the conventional…

June 12, 2019
Susan Mango newly elected EMBO member
Prof. Susan Mango at the Biozentrum, University of Basel, has been elected as new member of the prestigious European Molecular Biology Organization…

June 12, 2019
Reaching and Grasping – Learning fine motor coordination changes the brain
When we train the reaching for and grasping of objects, we also train our brain. In other words, this action brings about changes in the connections…

May 29, 2019
T3 Pharmaceuticals awarded highest endowed startup prize
T3 Pharmaceuticals AG wins the W.A. de Vigier Foundation’s highest endowed award for startup companies in Switzerland of CHF 100,000. The spin-off…